Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Bighelli

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Lancet (London, England)|June 25, 2013
Regulatory science in Europe: the case of schizophrenia trialsCorrado Barbui, Irene Bighelli
Plos Medicine|October 22, 2013
A new approach to psychiatric drug approval in EuropeCorrado Barbui, Irene Bighelli
The Lancet. Psychiatry|May 15, 2022
Digital aids for relapse prevention in schizophreniaToshi A Furukawa, Irene Bighelli
Plos One|June 3, 2017
Is the efficacy of antidepressants in panic disorder mediated by adverse events? A mediational analysisIrene Bighelli, Anna Borghesani, Corrado Barbui
The Lancet. Psychiatry|March 20, 2022
Relapse prevention in schizophrenia - Authors' replyIrene Bighelli, Alessandro Rodolico, Stefan Leucht
JAMA Psychiatry|June 3, 2026
Integrated Treatment Can Promote Recovery-ReplyNurul Husna Salahuddin, Stefan Leucht, Irene Bighelli
The Lancet. Psychiatry|March 20, 2022
Confidence of evidence should be considered in ranking of treatments in the network meta-analysis - Authors' replyIrene Bighelli, Alessandro Rodolico, Spyridon Siafis, et al.
The Cochrane Database of Systematic Reviews|February 7, 2024
Cognitive behavioural therapy without medication for schizophreniaIrene Bighelli, Oğulcan Çıray, Nurul Husna Salahuddin, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 7, 2019
The controversy about cognitive behavioural therapy for schizophreniaPeter McKenna, Stefan Leucht, Sammy Jauhar, et al.
Schizophrenia Bulletin|May 3, 2024
Update of the World Health Organization's Mental Health Gap Action Programme Guideline for Psychoses (Including Schizophrenia)Carolin Lorenz, Irene Bighelli, Fahmy Hanna, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Lancet (London, England)|June 25, 2013
Regulatory science in Europe: the case of schizophrenia trialsCorrado Barbui, Irene Bighelli
Plos Medicine|October 22, 2013
A new approach to psychiatric drug approval in EuropeCorrado Barbui, Irene Bighelli
The Lancet. Psychiatry|May 15, 2022
Digital aids for relapse prevention in schizophreniaToshi A Furukawa, Irene Bighelli
Plos One|June 3, 2017
Is the efficacy of antidepressants in panic disorder mediated by adverse events? A mediational analysisIrene Bighelli, Anna Borghesani, Corrado Barbui
The Lancet. Psychiatry|March 20, 2022
Relapse prevention in schizophrenia - Authors' replyIrene Bighelli, Alessandro Rodolico, Stefan Leucht
JAMA Psychiatry|June 3, 2026
Integrated Treatment Can Promote Recovery-ReplyNurul Husna Salahuddin, Stefan Leucht, Irene Bighelli
The Lancet. Psychiatry|March 20, 2022
Confidence of evidence should be considered in ranking of treatments in the network meta-analysis - Authors' replyIrene Bighelli, Alessandro Rodolico, Spyridon Siafis, et al.
The Cochrane Database of Systematic Reviews|February 7, 2024
Cognitive behavioural therapy without medication for schizophreniaIrene Bighelli, Oğulcan Çıray, Nurul Husna Salahuddin, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 7, 2019
The controversy about cognitive behavioural therapy for schizophreniaPeter McKenna, Stefan Leucht, Sammy Jauhar, et al.
Schizophrenia Bulletin|May 3, 2024
Update of the World Health Organization's Mental Health Gap Action Programme Guideline for Psychoses (Including Schizophrenia)Carolin Lorenz, Irene Bighelli, Fahmy Hanna, et al.
Pageof 9